CHRISTOPHER FIELDS: Open Payments
NPI 1184849119 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 11 payments from 7 companies in 2025. Trend: 2023 $585 · 2024 $847 · 2025 $992
Food & beverage: $992
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $263 |
| Alkermes, Inc. | 2 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $115 |
| Neurocrine BioSciences, Inc. | 1 | $108 |
| E.R. Squibb & Sons, L.L.C. | 1 | $105 |
| Janssen Pharmaceuticals, Inc | 1 | $89 |
| Janssen Scientific Affairs, LLC | 1 | $80 |
Products named: FANAPT, LYBALVI, CAPLYTA, ARISTADA, INGREZZA, COBENFY, SPRAVATO, INVEGA SUSTENNA.
Industry payments across SC — which companies pay providers there.
